Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: A prospective, crossover single-dwell study

Peritoneal Dialysis International

Volumn 28, Issue 1, 2008, Pages 35-43

  Fang, Wei ^a,b   Mullan, Robert ^a   Shah, Hemal ^a   Mujais, Salim ^c   Bargman, Joanne M ^a   Oreopoulos, Dimitrios G ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Acid base balance; Bicarbonate; Lactate; Solute transport; Ultrafiltration

Indexed keywords

BICARBONATE; BUFFER; DIALYSIS FLUID; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; BIOMATERIAL;

ACIDITY; ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; EQUILIBRIUM DIALYSIS; FEMALE; GLUCOSE TRANSPORT; HUMAN; KIDNEY FAILURE; KINETICS; MALE; MEMBRANE TRANSPORT; NURSE PRACTITIONER; PERITONEAL DIALYSIS; PERITONEUM; PH MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLUTE; ULTRAFILTRATION; ACID BASE BALANCE; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PH; TIME; TRANSPORT AT THE CELLULAR LEVEL;

ACID-BASE EQUILIBRIUM; ADULT; AGED; BICARBONATES; BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT; BUFFERS; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROSPECTIVE STUDIES; TIME FACTORS; ULTRAFILTRATION;

EID: 42449126330     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800108     Document Type: Article

References (29)

1. Coles GA, O'Donoghue DJ, Pritchard N, Ogg CS, Jani FM, Gokal R, et al. A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - final report. Nephrol Dial Transplant 1998; 13:3165-71.
2. Feriani M, Biasioli S, Borin D, Brendolan A, Gargantini L, Chiaramonte S, et al. Bicarbonate solutions for peritoneal dialysis: a reality. Int J Artif Organs 1985; 8:57-8.
3. Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, et al. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 2003; 14:2632-8.
4. Grossin N, Wautier MP, Wautier JL, Gane P, Taamma R, Boulanger E. Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid. Perit Dial Int 2006; 26:664-70.
5. Szeto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - a 1-year randomized control trial. Nephrol Dial Transplant 2007; 22:552-9.
6. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al.; Euro Balance Trial Group. The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
7. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 1992; 8:41-6.
8. Schambye HT, Pedersen FB, Christensen HK, Berthelsen H, Wang P. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios. Perit Dial Int 1993; 13(Suppl 2):S116-18.
9. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, et al. Bicarbonate and bicarbonate/lactate PD solutions for the treatment of infusion pain. Kidney Int 1998; 53:1061-7.
10. Otte K, Gonzalez MT, Bajo MA, del Peso G, Heaf J, Garcia Erauzkin G, et al. Clinical experience with a new bicarbonate (25 mmol/L) /lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 2003; 23:138-45.
11. Tranæus A, for the Bicarbonate/Lactate Study Group. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. Perit Dial Int 2000; 20:516-23.
12. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
13. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7:95-108.
14. Krediet RT, Boeschoten EW, Zuyderhoudt FM, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4:194-203.
15. Hernandez-Jaras J, Garcia H, Agramunt I. Peritoneal anionic transfers and their relationship with peritoneal transport and acid-base status. Nefrologia 2002; 22:42-8.
16. Heimburger O, Waniewski J, Wang T, Widstam U, Lindholm B, Tranæus A. Peritoneal transport with lactate 40 mmol/L (L) vs bicarbonate/lactate 25/15 mmol/L (BL) dialysis fluids [Abstract]. J Am Soc Nephrol 1998; 9:192A.
17. Heimburger O, Mujais S. Buffer transport in peritoneal dialysis. Kidney Int Suppl 2003; 88:S37-42.
18. Feriani M, Kirchgessner J, LaGreca G, Passlick-Deetjen J. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998; 54:1731-8.
19. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Boswald M, et al. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int 2002; 61:1527-36.
20. Simonsen O, Sterner G, Carlsson O, Wieslander A, Rippe B. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture. Perit Dial Int 2006; 26:353-9.
21. Montenegro J, Saracho R, Martinez I, Munoz RI, Ocharan J. Peritoneal transport with 3 different peritoneal solutions [Abstract]. Nephrol Dial Transplant 2003; 18(Suppl 4):216.
22. Montenegro J, Saracho R, Martinez I, Munoz RI, Ocharan JJ, Valladares E. Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions. Perit Dial Int 2006; 26:89-94.
23. Nourse P, van de Kar NC, Willems HL, Schroder C. No significant differences in peritoneal fluid handling in children using pH-neutral or acidic solutions. Perit Dial Int 2006; 26:587-92.
24. Fischbach M, Terzic J, Chauve S, Laugel V, Muller A, Haraldsson B. Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children. Nephrol Dial Transplant 2004; 19:925-32.
25. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. Kidney Int 1981; 20:397-402.
26. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002; 13:480-9.
27. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-25.
28. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20(Suppl 4): S22-42.
29. Rippe B, Venturoli D, Simonsen O, Arteaga JD. Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int 2004; 24:10-27.